Law360, New York (September 29, 2009) -- Eli Lilly & Co. is set to fork over $25.1 million to settle a lawsuit brought by the Connecticut Attorney General's Office for allegedly marketing its antipsychotic Zyprexa for unapproved uses and concealing the drug's serious side effects for more than a decade.
The settlement, announced Tuesday by Connecticut Attorney General Richard Blumenthal, marks the third such deal the pharmaceutical giant has brokered with states in recent months....
